EB Research Project Grants
Invests research teams and institutions for EB Research Project Grants in biotechnology, medical technology, and synthetic biology.
EB Research Partnership (EBRP), in collaboration with DEBRA of America, funds research targeting therapies for epidermolysis bullosa (EB), a rare and severe genetic blistering disease, through a venture-philanthropy model. Research Project Grants are one-year awards, renewable annually for up to five years of total funding, directed at commercially viable EB therapy development within a one-to-fou…
Research targeting commercially feasible EB therapies within 1–4 years; drug repurposing, pre-clinical or clinical work, or EB research tools. Basic research without commercial pathway is out of scope.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up